Climb Bio (CLYM)
Climb Bio on one page: short interest, daily short volume, fails to deliver, planned sales, large holders, 13F holders, earnings dates and insider trades. Listed on Nasdaq.
9.8M
Short interest
settlement 2026-10-15
10.3
Days to cover
+4.7 days vs prior
73.9%
Short share of volume
2026-11-02
30
Fails to deliver
settlement 2026-10-13
Thu 5 Nov
Next earnings
estimated date
-$1.4M
Insider flow, 90 days
0 buys, 1 sells
As of 2026-11-02.
Short interest
FINRA, twice a month. The newest 48 settlements in the table, 48 in the chart. JSONAs of 15 October 2026, short interest in CLYM is 9,787,492 shares, up 1,279,138 shares over the last month. Over the last 48 readings it ranged from 861,346 shares (15 October 2025) to 9,787,492 shares (15 October 2026). The latest reading sits at the top of that range. At the reported average volume of 946K shares a day that is 10.3 days to cover.
Embed this chart.The embed keeps its attribution line.
<iframe src="https://xoomar.com/embed/stocks/clym" width="100%" height="440" style="border:0;max-width:100%" loading="lazy" title="XOOMAR chart"></iframe>
| Settlement | Shares short | Change | Avg daily volume | Days to cover |
|---|---|---|---|---|
| 2026-10-15 | 9,787,492 | +0.7% | 946,178 | 10.34 |
| 2026-09-30 | 9,718,558 | +14.2% | 1,721,631 | 5.64 |
| 2026-09-15 | 8,508,354 | +16.5% | 1,880,063 | 4.53 |
| 2026-08-31 | 7,300,939 | -3.4% | 1,233,693 | 5.92 |
| 2026-08-14 | 7,557,264 | +7.4% | 1,199,851 | 6.30 |
| 2026-07-31 | 7,037,695 | +2.4% | 1,042,214 | 6.75 |
| 2026-07-15 | 6,871,210 | +34.8% | 1,361,582 | 5.05 |
| 2026-06-30 | 5,096,670 | +69.8% | 1,725,662 | 2.95 |
| 2026-06-15 | 3,001,897 | +57.3% | 1,530,335 | 1.96 |
| 2026-05-29 | 1,908,617 | -8.7% | 676,327 | 2.82 |
| 2026-05-15 | 2,090,647 | +17.7% | 972,970 | 2.15 |
| 2026-04-30 | 1,776,821 | +10.3% | 876,828 | 2.03 |
| 2026-04-15 | 1,610,632 | -9.3% | 532,264 | 3.03 |
| 2026-03-31 | 1,775,067 | -1.6% | 443,245 | 4.00 |
| 2026-03-13 | 1,803,792 | +2.9% | 570,075 | 3.16 |
| 2026-02-27 | 1,753,708 | -8.6% | 619,863 | 2.83 |
| 2026-02-13 | 1,918,833 | -5.5% | 555,656 | 3.45 |
| 2026-01-30 | 2,031,687 | +12.8% | 653,628 | 3.11 |
| 2026-01-15 | 1,801,497 | -0.8% | 879,045 | 2.05 |
| 2025-12-31 | 1,816,835 | -18.1% | 1,638,669 | 1.11 |
| 2025-12-15 | 2,219,442 | +18.0% | 3,204,007 | 1.00 |
| 2025-11-28 | 1,881,380 | +22.2% | 330,882 | 5.69 |
| 2025-11-14 | 1,540,104 | +19.5% | 413,689 | 3.72 |
| 2025-10-31 | 1,289,125 | +49.7% | 1,051,935 | 1.23 |
| 2025-10-15 | 861,346 | -6.3% | 844,602 | 1.02 |
| 2025-09-30 | 919,355 | +4.6% | 426,652 | 2.15 |
| 2025-09-15 | 878,949 | -27.2% | 444,348 | 1.98 |
| 2025-08-29 | 1,206,690 | +7.9% | 765,255 | 1.58 |
| 2025-08-15 | 1,118,221 | -14.9% | 908,498 | 1.23 |
| 2025-07-31 | 1,313,475 | -5.0% | 201,188 | 6.53 |
| 2025-07-15 | 1,382,404 | -2.2% | 217,184 | 6.37 |
| 2025-06-30 | 1,413,053 | -34.3% | 564,742 | 2.50 |
| 2025-06-13 | 2,151,584 | -2.0% | 234,179 | 9.19 |
| 2025-05-30 | 2,194,549 | +0.0% | 136,821 | 16.04 |
| 2025-05-15 | 2,194,652 | -5.6% | 143,422 | 15.30 |
| 2025-04-30 | 2,323,869 | +1.0% | 106,205 | 21.88 |
| 2025-04-15 | 2,300,096 | +4.8% | 205,478 | 11.19 |
| 2025-03-31 | 2,195,271 | +0.1% | 123,392 | 17.79 |
| 2025-03-14 | 2,192,464 | +9.8% | 234,658 | 9.34 |
| 2025-02-28 | 1,996,663 | +5.2% | 446,702 | 4.47 |
| 2025-02-14 | 1,898,020 | -55.8% | 342,151 | 5.55 |
| 2025-01-31 | 4,294,214 | -0.4% | 253,631 | 16.93 |
| 2025-01-15 | 4,310,782 | -10.5% | 826,259 | 5.22 |
| 2024-12-31 | 4,816,219 | -2.3% | 525,269 | 9.17 |
| 2024-12-13 | 4,930,125 | +0.7% | 139,743 | 35.28 |
| 2024-11-29 | 4,895,678 | -0.9% | 235,851 | 20.76 |
| 2024-11-15 | 4,940,821 | -0.8% | 379,610 | 13.02 |
| 2024-10-31 | 4,978,650 | +5.9% | 275,394 | 18.08 |
Daily short volume
FINRA Reg SHO, the last 30 sessions. JSONAs of 2 November 2026, the short share of CLYM volume is 73.9%, up 51.7 points over the last five sessions. Over the last 30 readings it ranged from 15.8% (27 October 2026) to 79.8% (28 October 2026). The latest reading sits at the top of that range. The latest reading is 15.2 points above the 30-session average of 58.7%, on 364K shares reported.
| Date | Short volume | Total volume | Short share | Exempt |
|---|---|---|---|---|
| 2026-11-02 | 269K | 364K | 73.9% | 0 |
| 2026-10-30 | 177K | 254K | 69.6% | 0 |
| 2026-10-29 | 153K | 248K | 61.6% | 0 |
| 2026-10-28 | 357K | 448K | 79.8% | 0 |
| 2026-10-27 | 331K | 2.1M | 15.8% | 64,455 |
| 2026-10-26 | 376K | 1.7M | 22.2% | 13,580 |
| 2026-10-23 | 107K | 139K | 77.3% | 0 |
| 2026-10-22 | 100K | 155K | 64.8% | 0 |
| 2026-10-21 | 232K | 336K | 69.0% | 0 |
| 2026-10-20 | 228K | 436K | 52.3% | 0 |
| 2026-10-19 | 168K | 350K | 48.0% | 2,932 |
| 2026-10-16 | 175K | 292K | 59.8% | 5,376 |
| 2026-10-15 | 120K | 164K | 73.0% | 0 |
| 2026-10-14 | 227K | 391K | 58.1% | 0 |
| 2026-10-13 | 145K | 242K | 59.7% | 0 |
| 2026-10-12 | 237K | 315K | 75.1% | 0 |
| 2026-10-09 | 160K | 217K | 73.4% | 92 |
| 2026-10-08 | 335K | 493K | 67.9% | 0 |
| 2026-10-07 | 176K | 281K | 62.8% | 400 |
| 2026-10-06 | 260K | 349K | 74.4% | 0 |
| 2026-10-05 | 183K | 411K | 44.6% | 0 |
| 2026-10-02 | 324K | 575K | 56.4% | 0 |
| 2026-10-01 | 142K | 293K | 48.6% | 0 |
| 2026-09-30 | 156K | 294K | 53.2% | 0 |
| 2026-09-29 | 223K | 436K | 51.0% | 5,262 |
| 2026-09-28 | 144K | 317K | 45.4% | 1 |
| 2026-09-25 | 249K | 622K | 40.0% | 0 |
| 2026-09-24 | 434K | 752K | 57.7% | 9,353 |
| 2026-09-23 | 536K | 917K | 58.4% | 19,036 |
| 2026-09-22 | 195K | 289K | 67.5% | 0 |
Fails to deliver
SEC, the last 30 settlement dates with a fail. JSONAs of 13 October 2026, the fails-to-deliver balance in CLYM is 30 shares, down 219 shares over the last settlement date. Over the last 30 readings it ranged from 4 shares (28 August 2026) to 92,256 shares (2 June 2026). The latest reading sits at the bottom of that range.
| Settlement | Shares failed | Price | Value |
|---|---|---|---|
| 2026-10-13 | 30 | $10.83 | $325 |
| 2026-09-28 | 249 | $11.66 | $3K |
| 2026-09-24 | 1,992 | $12.52 | $25K |
| 2026-09-21 | 34,170 | $14.05 | $480K |
| 2026-09-18 | 70 | $14.06 | $984 |
| 2026-09-09 | 279 | $15.90 | $4K |
| 2026-09-08 | 14,543 | $15.52 | $226K |
| 2026-08-28 | 4 | $15.06 | $60 |
| 2026-08-27 | 36 | $16.08 | $579 |
| 2026-08-24 | 975 | $17.28 | $17K |
| 2026-08-21 | 83 | $17.02 | $1K |
| 2026-08-17 | 27,387 | $16.33 | $447K |
| 2026-08-14 | 49 | $14.73 | $722 |
| 2026-08-04 | 3,560 | $11.81 | $42K |
| 2026-07-17 | 154 | $12.58 | $2K |
| 2026-07-16 | 139 | $13.87 | $2K |
| 2026-07-14 | 6,255 | $13.21 | $83K |
| 2026-07-02 | 54 | $13.29 | $718 |
| 2026-06-29 | 36,701 | $13.08 | $480K |
| 2026-06-26 | 2,301 | $12.66 | $29K |
| 2026-06-25 | 680 | $12.75 | $9K |
| 2026-06-24 | 7,452 | $12.30 | $92K |
| 2026-06-15 | 818 | $11.44 | $9K |
| 2026-06-10 | 58,000 | $11.14 | $646K |
| 2026-06-02 | 92,256 | $11.80 | $1.1M |
| 2026-06-01 | 363 | $10.96 | $4K |
| 2026-05-19 | 100 | $9.88 | $988 |
| 2026-05-14 | 103 | $11.41 | $1K |
| 2026-05-13 | 7,860 | $11.17 | $88K |
| 2026-04-24 | 64 | $9.02 | $577 |
Insider trades
SEC Form 4, newest first. JSONInsiders at CLYM reported 1 open-market sell worth $1.4M in the last 90 days and no open-market buys. Latest filing: RA CAPITAL MANAGEMENT, L.P. (Director, 10% owner) on 2026-09-28.
| Date | Insider | Title | Type | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|---|
| 2026-09-28 | RA CAPITAL MANAGEMENT, L.P. | Director, 10% owner | Exercise or conversion | 10K | $7.89 | $79K | 30K |
| 2026-09-28 | RA CAPITAL MANAGEMENT, L.P. | Director, 10% owner | Exercise or conversion | 10K | $3.00 | $30K | 20K |
| 2026-09-28 | RA CAPITAL MANAGEMENT, L.P. | Director, 10% owner | Exercise or conversion | 40K | $1.29 | $52K | 70K |
| 2026-09-28 | RA CAPITAL MANAGEMENT, L.P. | Director, 10% owner | Exercise or conversion | 10K | $3.46 | $35K | 10K |
| 2026-09-15 | Thomas Stephen Basil | Director | Sell | 100K | $13.67 | $1.4M | 468K |
| 2026-06-29 | Brennan Aoife | President and CEO | Sell | 31K | $13.17 | $407K | 88K |
| 2026-06-27 | Brennan Aoife | President and CEO | Exercise or conversion | 69K | price not stated in the filing | not stated | 119K |
| 2026-02-26 | Thomas Stephen Basil | Director | Sell | 16K | $7.01 | $114K | 155K |
| 2026-02-25 | Thomas Stephen Basil | Director | Sell | 34K | $7.00 | $236K | 171K |
| 2026-02-13 | Thomas Stephen Basil | Director | Sell | 10K | $5.81 | $58K | 205K |
| 2026-02-12 | Thomas Stephen Basil | Director | Sell | 90K | $5.23 | $471K | 215K |
| 2026-01-05 | RA Capital Healthcare Fund LP | Director,TenPercentOwner | Buy | 7K | $3.50 | $25K | 3.4M |
| 2026-01-05 | RA CAPITAL MANAGEMENT, L.P. | Director, 10% owner | Buy | 7K | $3.50 | $25K | 3.4M |
| 2025-12-12 | Kolchinsky Peter | Director,TenPercentOwner | Buy | 101K | $2.86 | $290K | 3.4M |
| 2025-12-12 | RA CAPITAL MANAGEMENT, L.P. | Director, 10% owner | Buy | 101K | $2.86 | $290K | 3.4M |
| 2025-12-11 | Kolchinsky Peter | Director,TenPercentOwner | Returned to company | 20.4M | $0.00 | $0 | 3.1M |
| 2025-12-11 | Kolchinsky Peter | Director,TenPercentOwner | Buy | 213K | $2.18 | $465K | 3.3M |
| 2025-12-11 | RA CAPITAL MANAGEMENT, L.P. | Director, 10% owner | Buy | 213K | $2.18 | $465K | 3.3M |
| 2025-12-11 | RA CAPITAL MANAGEMENT, L.P. | Director, 10% owner | Returned to company | 20.4M | $0.00 | $0 | 3.1M |
| 2025-08-07 | Thomas Stephen Basil | Director | Grant | 100K | $0.00 | $0 | 305K |
| 2025-06-30 | Brennan Aoife | President and CEO | Sell | 21K | $1.22 | $25K | 48K |
| 2025-06-27 | Thomas Stephen Basil | Director | Exercise or conversion | 25K | price not stated in the filing | not stated | 204K |
| 2025-06-27 | Brennan Aoife | President and CEO | Exercise or conversion | 69K | price not stated in the filing | not stated | 69K |
| 2025-06-20 | Pimblett Emily | SVP, Finance & CAO | Sell | 1K | $1.24 | $2K | 19K |
| 2025-06-18 | Pimblett Emily | SVP, Finance & CAO | Exercise or conversion | 5K | price not stated in the filing | not stated | 20K |
| 2025-03-27 | Thomas Stephen Basil | Director | Exercise or conversion | 25K | price not stated in the filing | not stated | 179K |
| 2025-03-20 | Pimblett Emily | SVP, Finance & CAO | Sell | 1K | $1.31 | $2K | 15K |
| 2025-03-18 | Pimblett Emily | SVP, Finance & CAO | Exercise or conversion | 5K | price not stated in the filing | not stated | 16K |
| 2025-01-01 | Thomas Stephen Basil | Director | Exercise or conversion | 50K | price not stated in the filing | not stated | 154K |
| 2024-12-19 | Pimblett Emily | CHIEF ACCOUNTING OFFICER | Sell | 1K | $2.02 | $2K | 11K |
| 2024-12-18 | Pimblett Emily | CHIEF ACCOUNTING OFFICER | Exercise or conversion | 5K | price not stated in the filing | not stated | 13K |
Form 4 filings are due within two business days of the trade. Insiders sell for many reasons that say nothing about the company; open-market buys are rarer.
Planned sales (Form 144)
Newest first. JSON4 Form 144 notices on file for CLYM worth $2.7M at the prices reported; 1 in the last 90 days worth $1.5M. Latest: STEPHEN THOMAS filed on 2026-09-15 to sell 100,000 shares ($1.5M) from 2026-09-15.
| Filed | Seller | Shares | Market value | Of outstanding | Sale from | Broker |
|---|---|---|---|---|---|---|
| 2026-09-15 | STEPHEN THOMASDirector | 100K | $1.5M | 0.174% | 2026-09-15 | Morgan Stanley Smith Barney LLC Executive Financial Services |
| 2026-06-30 | AOIFE BRENNANOfficer, Director | 31K | $407K | 0.054% | 2026-06-29 | E-TRADE FINANCIAL CORPORATION |
| 2026-02-25 | STEPHEN THOMASDirector | 50K | $318K | 0.073% | 2026-02-25 | Morgan Stanley Smith Barney LLC Executive Financial Services |
| 2026-02-12 | STEPHEN THOMASDirector | 100K | $556K | 0.147% | 2026-02-12 | Morgan Stanley Smith Barney LLC Executive Financial Services |
Large holders (13D and 13G)
One row per reporting person with its latest filing, newest first. JSON16 holders report 5% or more of CLYM in their latest filing, 5 on Schedule 13D (active intent). The largest reported stake is Peter Kolchinsky at 33.0% of the class (23,249,186 shares), filed 2026-07-07 for an event on 2026-07-02.
| Filed | Form | Holder | Shares | Of class | Event |
|---|---|---|---|---|---|
| 2026-10-28 | 13G | James E. Flynnindividual | 3.1M | 5.3% | 2026-10-27 |
| 2026-10-28 | 13G | Deerfield Partners, L.P.partnership | 3.1M | 5.3% | 2026-10-27 |
| 2026-10-28 | 13G | Deerfield Management Company, L.P.partnership | 3.1M | 5.3% | 2026-10-27 |
| 2026-10-28 | 13G | Deerfield Mgmt, L.P.partnership | 3.1M | 5.3% | 2026-10-27 |
| 2026-10-27 | 13G | BlackRock, Inc.parent holding company | 2.9M | 5.0% | 2026-09-30 |
| 2026-08-14 | 13G/Ano. 1 | MPM BioImpact LLCinvestment adviser | 0 | 0.0% | 2026-06-30 |
| 2026-07-08 | 13G | Abigail P. Johnsonindividual | 6.8M | 11.9% | 2026-06-30 |
| 2026-07-08 | 13G | FMR LLCparent holding company | 6.8M | 11.9% | 2026-06-30 |
| 2026-07-07 | 13D/Ano. 10 | Peter Kolchinskyparent holding company, individual | 23.2M | 33.0% | 2026-07-02 |
| 2026-07-07 | 13D/Ano. 10 | RA Capital Management, L.P.investment adviser, partnership | 23.2M | 33.0% | 2026-07-02 |
| 2026-07-07 | 13D/Ano. 10 | Rajeev Shahparent holding company, individual | 23.2M | 33.0% | 2026-07-02 |
| 2026-07-07 | 13D/Ano. 10 | RA Capital Healthcare Fund, L.P.partnership | 16.9M | 24.1% | 2026-07-02 |
| 2026-07-07 | 13D/Ano. 10 | RA Capital Nexus Fund III, L.P.partnership | 3.7M | 6.4% | 2026-07-02 |
| 2026-04-29 | 13D/Ano. 9 | Sera Medicines, LLCother entity | 2.5M | 4.3% | 2026-04-27 |
| 2025-10-16 | 13D/Ano. 5 | AI ETI LLCother entity | 0 | 0.0% | 2025-10-14 |
| 2025-10-16 | 13D/Ano. 5 | Access Industries Holdings LLCother entity | 0 | 0.0% | 2025-10-14 |
| 2025-10-16 | 13D/Ano. 5 | Access Industries Management, LLCother entity | 0 | 0.0% | 2025-10-14 |
| 2025-10-16 | 13D/Ano. 5 | Len Blavatnikindividual | 0 | 0.0% | 2025-10-14 |
| 2025-09-18 | 13G | Pontifax VI G.P. L.P.partnership | 5.2M | 7.7% | 2024-06-27 |
| 2025-09-18 | 13G | Pontifax Management 4 G.P. (2015) Ltd.corporation | 5.2M | 7.7% | 2024-06-27 |
| 2025-09-18 | 13G | Ran Nussbaumindividual | 5.2M | 7.7% | 2024-06-27 |
| 2025-09-18 | 13G | Tomer Karivindividual | 5.2M | 7.7% | 2024-06-27 |
13F holders
Tracked managers holding CLYM at their latest 13F. JSON5 of the 30 tracked managers held CLYM at their latest 13F, $33.6M in total at quarter-end prices. Citadel Advisors is the largest at $16.9M (0.0% of its portfolio) as of 2026-06-30. Over the prior quarter 2 added shares and 3 cut.
| Fund | Quarter | Shares | Value | Of portfolio | Change in shares |
|---|---|---|---|---|---|
| Citadel Advisors | 2026-06-30 | 1.3M | $16.9M | 0.00% | +952K |
| Millennium Management | 2026-06-30 | 908K | $11.8M | 0.00% | -368K |
| Renaissance Technologies | 2026-06-30 | 193K | $2.5M | 0.00% | -25K |
| Two Sigma Investments | 2026-06-30 | 148K | $1.9M | 0.00% | -162K |
| D. E. Shaw & Co. | 2026-06-30 | 29K | $376K | 0.00% | new |
Only the 30 tracked managers on the funds hub; a 13F reports long positions in US listed stock at quarter end, 45 days late, and says nothing about shorts or positions sold since.
What this page is
Climb Bio in the regulatory record
Regulators publish company data in separate files that never sit next to each other: FINRA's twice-monthly short interest, its daily short sale volume, the SEC's fails-to-deliver counts, and each insider's Form 4. A company page puts those series for one ticker on one URL, with planned sales, large holders, 13F holders and financials beside them, so the short position, the daily flow, the settlement fails and what insiders are doing can be read together.
Each section has its own history table, a one-line summary of the latest figures and its own JSON and CSV links, and says when its source last updated.
This page follows Climb Bio (CLYM), SEC CIK 1768446, listed on Nasdaq. The cross-market tables live on the short interest and insider transactions hubs.
Source and updates
- Short interest
- FINRA consolidated short interestSource: FINRA.Twice a month, about eight business days after settlement. Latest 2026-10-15.JSON and CSV
- Daily short volume
- FINRA Reg SHO daily filesSource: FINRA.Every trading day, the morning after FINRA posts it. Latest 2026-11-02.JSON and CSV
- Fails to deliver
- SEC fails-to-deliver dataSource: SEC.Twice a month, a few weeks after the half month ends. Latest 2026-10-13.JSON and CSV
- Planned sales
- SEC EDGAR Form 144Source: SEC.New notices appear shortly after the SEC posts them; a notice is filed on or before the sale. Latest 2026-09-15.JSON and CSV
- Large holders
- SEC EDGAR Schedule 13D and 13GSource: SEC.New filings appear shortly after the SEC posts them. A 13D is due within five business days of crossing 5%; a 13G follows the passive schedule. Latest 2026-10-28.JSON and CSV
- 13F holders
- SEC EDGAR Form 13F-HRSource: SEC.Quarterly, filed within 45 days of quarter end; 30 tracked managers. Latest 2026-06-30.JSON and CSV
- Earnings dates
- SEC EDGAR 8-K filings (Item 2.02)Source: SEC.Twice a day. Reported dates come from the company's 8-K filings; the next date is marked as an estimate until the 8-K arrives. Latest 2026-08-06.JSON and CSV
- Insider trades
- SEC EDGAR Form 4Source: SEC.New filings appear shortly after the SEC posts them; they're due two business days after the trade. Latest 2026-09-28.JSON and CSV
- Company record
- EDGAR filing index for CIK 1768446Ticker, name and exchange from the SEC's company list, refreshed weekly.
- Rate limits
- 10 requests a minute without a key, 30 with a free key from a free account.
How to read it
- Read the position against the flow: rising short interest with a high daily short share is new shorting; rising short interest with a normal short share is old shorts holding on.
- Insider buys next to a large short position are rare and stand out; insider sells next to one are common and mean little.
- Fails to deliver matter relative to the float, not in absolute shares; a million failed shares in a mega cap is noise.
Analysis of what the data shows, not advice. XOOMAR does not recommend buying, selling or holding anything.
Other company pages
- STESTERIS
- STLDSteel Dynamics
- STRCStrategy
- STRLSterling Infrastructure
- STTState Street
- STXSeagate Technology Holdings
- STZConstellation Brands
- SUISun Communities
- SUNBSunbelt Rentals Holdings
- SWSmurfit Westrock
- SWKStanley Black & Decker
- SWKSSkyworks Solutions
- SXTCChina SXT Pharmaceuticals
- SYFSynchrony Financial
- SYKStryker
- SYNASynaptics
- SYRESpyre Therapeutics
- SYYSysco
- TAT&T
- TAPMolson Coors
- TCOMTrip.com Group
- TDToronto-Dominion Bank
- TDGTransDigm Group
- TDYTeledyne Technologies
Datasets
Frequently Asked Questions
How much of CLYM is sold short?
What is CLYM's daily short volume?
Does CLYM have fails to deliver?
Are CLYM insiders buying or selling?
Have CLYM insiders filed to sell?
Who owns 5% or more of CLYM?
Which tracked 13F managers own CLYM?
Data on this page is provided for informational purposes only and is not financial advice. See our editorial policy.